rs121908224

Variant summary

Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM2PP3_ModeratePP5_Moderate

The NM_001127222.2(CACNA1A):​c.5080G>T​(p.Val1694Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1694I) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CACNA1A
NM_001127222.2 missense

Scores

16
1
2

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 6.08

Publications

0 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 8 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 13 uncertain in NM_001127222.2
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.929
PP5
Variant 19-13235262-C-A is Pathogenic according to our data. Variant chr19-13235262-C-A is described in ClinVar as Pathogenic. ClinVar VariationId is 2925638.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.5080G>T p.Val1694Phe missense_variant Exon 33 of 47 ENST00000360228.11 NP_001120694.1
CACNA1ANM_001127221.2 linkc.5083G>T p.Val1695Phe missense_variant Exon 33 of 47 ENST00000638009.2 NP_001120693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.5080G>T p.Val1694Phe missense_variant Exon 33 of 47 1 NM_001127222.2 ENSP00000353362.5
CACNA1AENST00000638009.2 linkc.5083G>T p.Val1695Phe missense_variant Exon 33 of 47 1 NM_001127221.2 ENSP00000489913.1
CACNA1AENST00000638029.1 linkc.5098G>T p.Val1700Phe missense_variant Exon 34 of 48 5 ENSP00000489829.1
CACNA1AENST00000573710.7 linkc.5086G>T p.Val1696Phe missense_variant Exon 33 of 47 5 ENSP00000460092.3
CACNA1AENST00000635727.1 linkc.5083G>T p.Val1695Phe missense_variant Exon 33 of 47 5 ENSP00000490001.1
CACNA1AENST00000637769.1 linkc.5083G>T p.Val1695Phe missense_variant Exon 33 of 47 1 ENSP00000489778.1
CACNA1AENST00000636012.1 linkc.5083G>T p.Val1695Phe missense_variant Exon 33 of 46 5 ENSP00000490223.1
CACNA1AENST00000637736.1 linkc.4942G>T p.Val1648Phe missense_variant Exon 32 of 46 5 ENSP00000489861.1
CACNA1AENST00000636389.1 linkc.5083G>T p.Val1695Phe missense_variant Exon 33 of 47 5 ENSP00000489992.1
CACNA1AENST00000637432.1 linkc.5098G>T p.Val1700Phe missense_variant Exon 34 of 48 5 ENSP00000490617.1
CACNA1AENST00000636549.1 linkc.5089G>T p.Val1697Phe missense_variant Exon 34 of 48 5 ENSP00000490578.1
CACNA1AENST00000637927.1 linkc.5086G>T p.Val1696Phe missense_variant Exon 33 of 47 5 ENSP00000489715.1
CACNA1AENST00000635895.1 linkc.5083G>T p.Val1695Phe missense_variant Exon 33 of 47 5 ENSP00000490323.1
CACNA1AENST00000637276.1 linkc.5083G>T p.Val1695Phe missense_variant Exon 33 of 46 5 ENSP00000489777.1
CACNA1AENST00000636768.2 linkn.5083G>T non_coding_transcript_exon_variant Exon 33 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.*261G>T non_coding_transcript_exon_variant Exon 34 of 47 ENSP00000519091.1
CACNA1AENST00000713789.1 linkn.*261G>T 3_prime_UTR_variant Exon 34 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1442784
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
715984
African (AFR)
AF:
0.00
AC:
0
AN:
33026
American (AMR)
AF:
0.00
AC:
0
AN:
40806
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25756
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38820
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83696
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52240
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1102936
Other (OTH)
AF:
0.00
AC:
0
AN:
59754
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Pathogenic:1
Oct 16, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 1695 of the CACNA1A protein (p.Val1695Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with CACNA1A-related conditions (PMID: 18498393). In at least one individual the variant was observed to be de novo. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CACNA1A protein function. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.55
D
BayesDel_noAF
Pathogenic
0.56
CADD
Uncertain
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.24
.;.;T;.;.;.;.;.;D;.;.;T;.;.;.;T;.;.;.
Eigen
Pathogenic
0.82
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.99
D;D;D;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.67
D
MetaRNN
Pathogenic
0.93
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.2
.;.;.;.;M;.;.;.;.;.;.;.;.;.;M;.;.;.;.
PhyloP100
6.1
PrimateAI
Pathogenic
0.92
D
PROVEAN
Pathogenic
-4.5
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Pathogenic
0.95
Sift
Pathogenic
0.0
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Pathogenic
0.0
D;D;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.84
MutPred
0.70
.;.;Loss of catalytic residue at V1695 (P = 0.1017);Loss of catalytic residue at V1695 (P = 0.1017);Loss of catalytic residue at V1695 (P = 0.1017);.;.;Loss of catalytic residue at V1695 (P = 0.1017);.;.;.;Loss of catalytic residue at V1695 (P = 0.1017);Loss of catalytic residue at V1695 (P = 0.1017);.;Loss of catalytic residue at V1695 (P = 0.1017);.;.;.;.;
MVP
0.98
MPC
1.6
ClinPred
1.0
D
GERP RS
5.1
Varity_R
0.83
gMVP
0.99
Mutation Taster
=0/100
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908224; hg19: chr19-13346076; API